Rating History for Turning Point Therapeutics Inc. (TPTX) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/13/2022 | Andrew S. Berens | Downgrade | Market Perform (Outperform) |
76.00 (101.00) |
74.47 (76.01) |
2.07% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
